img

Global Targeting Small Molecule Tumor Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Targeting Small Molecule Tumor Drugs Market Research Report 2024

These compounds are usually ≤500Da size and are often administered orally. Their small size also allows them to translocate through the plasma membrane and interact with the cytoplasmic domain of cell-surface receptors and intracellular signaling molecules.
According to Mr Accuracy reports new survey, global Targeting Small Molecule Tumor Drugs market is projected to reach US$ 97020 million in 2029, increasing from US$ 50220 million in 2022, with the CAGR of 9.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Targeting Small Molecule Tumor Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Targeting Small Molecule Tumor Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Segment by Type
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Targeting Small Molecule Tumor Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sorafenib
1.2.3 Lenvatinib
1.2.4 Regorafenib
1.2.5 Osimertinib
1.2.6 Anlotinib
1.2.7 Alectinib
1.2.8 Other
1.3 Market by Application
1.3.1 Global Targeting Small Molecule Tumor Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeting Small Molecule Tumor Drugs Market Perspective (2018-2029)
2.2 Targeting Small Molecule Tumor Drugs Growth Trends by Region
2.2.1 Global Targeting Small Molecule Tumor Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeting Small Molecule Tumor Drugs Historic Market Size by Region (2018-2024)
2.2.3 Targeting Small Molecule Tumor Drugs Forecasted Market Size by Region (2024-2029)
2.3 Targeting Small Molecule Tumor Drugs Market Dynamics
2.3.1 Targeting Small Molecule Tumor Drugs Industry Trends
2.3.2 Targeting Small Molecule Tumor Drugs Market Drivers
2.3.3 Targeting Small Molecule Tumor Drugs Market Challenges
2.3.4 Targeting Small Molecule Tumor Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeting Small Molecule Tumor Drugs Players by Revenue
3.1.1 Global Top Targeting Small Molecule Tumor Drugs Players by Revenue (2018-2024)
3.1.2 Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Targeting Small Molecule Tumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeting Small Molecule Tumor Drugs Revenue
3.4 Global Targeting Small Molecule Tumor Drugs Market Concentration Ratio
3.4.1 Global Targeting Small Molecule Tumor Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeting Small Molecule Tumor Drugs Revenue in 2022
3.5 Targeting Small Molecule Tumor Drugs Key Players Head office and Area Served
3.6 Key Players Targeting Small Molecule Tumor Drugs Product Solution and Service
3.7 Date of Enter into Targeting Small Molecule Tumor Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeting Small Molecule Tumor Drugs Breakdown Data by Type
4.1 Global Targeting Small Molecule Tumor Drugs Historic Market Size by Type (2018-2024)
4.2 Global Targeting Small Molecule Tumor Drugs Forecasted Market Size by Type (2024-2029)
5 Targeting Small Molecule Tumor Drugs Breakdown Data by Application
5.1 Global Targeting Small Molecule Tumor Drugs Historic Market Size by Application (2018-2024)
5.2 Global Targeting Small Molecule Tumor Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeting Small Molecule Tumor Drugs Market Size (2018-2029)
6.2 North America Targeting Small Molecule Tumor Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024)
6.4 North America Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeting Small Molecule Tumor Drugs Market Size (2018-2029)
7.2 Europe Targeting Small Molecule Tumor Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024)
7.4 Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size (2018-2029)
8.2 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeting Small Molecule Tumor Drugs Market Size (2018-2029)
9.2 Latin America Targeting Small Molecule Tumor Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024)
9.4 Latin America Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size (2018-2029)
10.2 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeting Small Molecule Tumor Drugs Introduction
11.1.4 Bayer Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.1.5 Bayer Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Targeting Small Molecule Tumor Drugs Introduction
11.2.4 Eisai Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.2.5 Eisai Recent Development
11.3 Zelgen
11.3.1 Zelgen Company Detail
11.3.2 Zelgen Business Overview
11.3.3 Zelgen Targeting Small Molecule Tumor Drugs Introduction
11.3.4 Zelgen Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.3.5 Zelgen Recent Development
11.4 Cipla
11.4.1 Cipla Company Detail
11.4.2 Cipla Business Overview
11.4.3 Cipla Targeting Small Molecule Tumor Drugs Introduction
11.4.4 Cipla Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.4.5 Cipla Recent Development
11.5 Natco Pharma
11.5.1 Natco Pharma Company Detail
11.5.2 Natco Pharma Business Overview
11.5.3 Natco Pharma Targeting Small Molecule Tumor Drugs Introduction
11.5.4 Natco Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.5.5 Natco Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Targeting Small Molecule Tumor Drugs Introduction
11.6.4 AstraZeneca Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Targeting Small Molecule Tumor Drugs Introduction
11.7.4 Novartis Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.7.5 Novartis Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Targeting Small Molecule Tumor Drugs Introduction
11.8.4 Roche Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Targeting Small Molecule Tumor Drugs Introduction
11.10.4 Pfizer Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.10.5 Pfizer Recent Development
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Detail
11.11.2 BEACON Pharma Business Overview
11.11.3 BEACON Pharma Targeting Small Molecule Tumor Drugs Introduction
11.11.4 BEACON Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.11.5 BEACON Pharma Recent Development
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Detail
11.12.2 Jiangxi Shanxiang Business Overview
11.12.3 Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Introduction
11.12.4 Jiangxi Shanxiang Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.12.5 Jiangxi Shanxiang Recent Development
11.13 Yao Pharma
11.13.1 Yao Pharma Company Detail
11.13.2 Yao Pharma Business Overview
11.13.3 Yao Pharma Targeting Small Molecule Tumor Drugs Introduction
11.13.4 Yao Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.13.5 Yao Pharma Recent Development
11.14 CSPC
11.14.1 CSPC Company Detail
11.14.2 CSPC Business Overview
11.14.3 CSPC Targeting Small Molecule Tumor Drugs Introduction
11.14.4 CSPC Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.14.5 CSPC Recent Development
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Detail
11.15.2 CHIATAI Tianqing Business Overview
11.15.3 CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Introduction
11.15.4 CHIATAI Tianqing Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.15.5 CHIATAI Tianqing Recent Development
11.16 Simcere
11.16.1 Simcere Company Detail
11.16.2 Simcere Business Overview
11.16.3 Simcere Targeting Small Molecule Tumor Drugs Introduction
11.16.4 Simcere Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024)
11.16.5 Simcere Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sorafenib
Table 3. Key Players of Lenvatinib
Table 4. Key Players of Regorafenib
Table 5. Key Players of Osimertinib
Table 6. Key Players of Anlotinib
Table 7. Key Players of Alectinib
Table 8. Key Players of Other
Table 9. Global Targeting Small Molecule Tumor Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Targeting Small Molecule Tumor Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Targeting Small Molecule Tumor Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 12. Global Targeting Small Molecule Tumor Drugs Market Share by Region (2018-2024)
Table 13. Global Targeting Small Molecule Tumor Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Targeting Small Molecule Tumor Drugs Market Share by Region (2024-2029)
Table 15. Targeting Small Molecule Tumor Drugs Market Trends
Table 16. Targeting Small Molecule Tumor Drugs Market Drivers
Table 17. Targeting Small Molecule Tumor Drugs Market Challenges
Table 18. Targeting Small Molecule Tumor Drugs Market Restraints
Table 19. Global Targeting Small Molecule Tumor Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 20. Global Targeting Small Molecule Tumor Drugs Market Share by Players (2018-2024)
Table 21. Global Top Targeting Small Molecule Tumor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeting Small Molecule Tumor Drugs as of 2022)
Table 22. Ranking of Global Top Targeting Small Molecule Tumor Drugs Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Targeting Small Molecule Tumor Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Targeting Small Molecule Tumor Drugs Product Solution and Service
Table 26. Date of Enter into Targeting Small Molecule Tumor Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Targeting Small Molecule Tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 29. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Type (2018-2024)
Table 30. Global Targeting Small Molecule Tumor Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Type (2024-2029)
Table 32. Global Targeting Small Molecule Tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 33. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Application (2018-2024)
Table 34. Global Targeting Small Molecule Tumor Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Application (2024-2029)
Table 36. North America Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 41. Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 44. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 47. Latin America Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 50. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 51. Bayer Company Detail
Table 52. Bayer Business Overview
Table 53. Bayer Targeting Small Molecule Tumor Drugs Product
Table 54. Bayer Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Eisai Company Detail
Table 57. Eisai Business Overview
Table 58. Eisai Targeting Small Molecule Tumor Drugs Product
Table 59. Eisai Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 60. Eisai Recent Development
Table 61. Zelgen Company Detail
Table 62. Zelgen Business Overview
Table 63. Zelgen Targeting Small Molecule Tumor Drugs Product
Table 64. Zelgen Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 65. Zelgen Recent Development
Table 66. Cipla Company Detail
Table 67. Cipla Business Overview
Table 68. Cipla Targeting Small Molecule Tumor Drugs Product
Table 69. Cipla Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 70. Cipla Recent Development
Table 71. Natco Pharma Company Detail
Table 72. Natco Pharma Business Overview
Table 73. Natco Pharma Targeting Small Molecule Tumor Drugs Product
Table 74. Natco Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 75. Natco Pharma Recent Development
Table 76. AstraZeneca Company Detail
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Targeting Small Molecule Tumor Drugs Product
Table 79. AstraZeneca Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Targeting Small Molecule Tumor Drugs Product
Table 84. Novartis Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche Targeting Small Molecule Tumor Drugs Product
Table 89. Roche Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Bristol-Myers Squibb Company Detail
Table 92. Bristol-Myers Squibb Business Overview
Table 93. Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Product
Table 94. Bristol-Myers Squibb Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 95. Bristol-Myers Squibb Recent Development
Table 96. Pfizer Company Detail
Table 97. Pfizer Business Overview
Table 98. Pfizer Targeting Small Molecule Tumor Drugs Product
Table 99. Pfizer Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. BEACON Pharma Company Detail
Table 102. BEACON Pharma Business Overview
Table 103. BEACON Pharma Targeting Small Molecule Tumor Drugs Product
Table 104. BEACON Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 105. BEACON Pharma Recent Development
Table 106. Jiangxi Shanxiang Company Detail
Table 107. Jiangxi Shanxiang Business Overview
Table 108. Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Product
Table 109. Jiangxi Shanxiang Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 110. Jiangxi Shanxiang Recent Development
Table 111. Yao Pharma Company Detail
Table 112. Yao Pharma Business Overview
Table 113. Yao Pharma Targeting Small Molecule Tumor Drugs Product
Table 114. Yao Pharma Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 115. Yao Pharma Recent Development
Table 116. CSPC Company Detail
Table 117. CSPC Business Overview
Table 118. CSPC Targeting Small Molecule Tumor Drugs Product
Table 119. CSPC Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 120. CSPC Recent Development
Table 121. CHIATAI Tianqing Company Detail
Table 122. CHIATAI Tianqing Business Overview
Table 123. CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Product
Table 124. CHIATAI Tianqing Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 125. CHIATAI Tianqing Recent Development
Table 126. Simcere Company Detail
Table 127. Simcere Business Overview
Table 128. Simcere Targeting Small Molecule Tumor Drugs Product
Table 129. Simcere Revenue in Targeting Small Molecule Tumor Drugs Business (2018-2024) & (US$ Million)
Table 130. Simcere Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeting Small Molecule Tumor Drugs Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Targeting Small Molecule Tumor Drugs Market Share by Type: 2022 VS 2029
Figure 3. Sorafenib Features
Figure 4. Lenvatinib Features
Figure 5. Regorafenib Features
Figure 6. Osimertinib Features
Figure 7. Anlotinib Features
Figure 8. Alectinib Features
Figure 9. Other Features
Figure 10. Global Targeting Small Molecule Tumor Drugs Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 11. Global Targeting Small Molecule Tumor Drugs Market Share by Application: 2022 VS 2029
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Other Case Studies
Figure 15. Targeting Small Molecule Tumor Drugs Report Years Considered
Figure 16. Global Targeting Small Molecule Tumor Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Targeting Small Molecule Tumor Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Targeting Small Molecule Tumor Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Targeting Small Molecule Tumor Drugs Market Share by Players in 2022
Figure 20. Global Top Targeting Small Molecule Tumor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeting Small Molecule Tumor Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Targeting Small Molecule Tumor Drugs Revenue in 2022
Figure 22. North America Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Targeting Small Molecule Tumor Drugs Market Share by Country (2018-2029)
Figure 24. United States Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Targeting Small Molecule Tumor Drugs Market Share by Country (2018-2029)
Figure 28. Germany Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Share by Region (2018-2029)
Figure 36. China Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Targeting Small Molecule Tumor Drugs Market Share by Country (2018-2029)
Figure 44. Mexico Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Share by Country (2018-2029)
Figure 48. Turkey Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Targeting Small Molecule Tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 51. Eisai Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 52. Zelgen Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 53. Cipla Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 54. Natco Pharma Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 56. Novartis Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 57. Roche Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 59. Pfizer Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 60. BEACON Pharma Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 61. Jiangxi Shanxiang Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 62. Yao Pharma Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 63. CSPC Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 64. CHIATAI Tianqing Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 65. Simcere Revenue Growth Rate in Targeting Small Molecule Tumor Drugs Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries